Michael Girardi

Regulation of Cutaneous Malignancy by γδ T Cells

Michael Girardi, David Oppenheim, Carrie R. Steele et al. · Science · 2001 · 964 citations · Full text

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A. Olsen, Sean Whittaker, Youn H. Kim et al. · Journal of Clinical Oncology · 2011 · 641 citations · Full text

Immunodeficiencies, Immunology, Clinical End Points +17

CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets

Julie C. Ribot, Ana deBarros, Dick John Pang et al. · Nature Immunology · 2009 · 605 citations · Full text

Inflammation, Lymphocyte Development, Immune Cell Development +12

γδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity

Yunfei Gao, Wancai Yang, Meng Pan et al. · The Journal of Experimental Medicine · 2003 · 434 citations · Full text

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

David Oppenheim, Scott Roberts, Sarah L. Clarke et al. · Nature Immunology · 2005 · 433 citations

Nkg2d Receptor, Natural Cytotoxicity, Natural Killer Cells +13